Assessment of effect of intravenous ketamine in suicidal ideas among patients with major depressive disorder in comparison with control group

Phase 2

• Conditions: Suicide attempt- Depression.; Severe depressive episode without psychotic symptoms, Personal history of self-harm; z91.5, F3

• Registration Number: IRCT2015030921397N1
• Lead Sponsor: Vice chancellor for research, Hormozgan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

depression diagnosis due to DSM IV criteria; benign major depression episode; suicidal thoughts; no use of antidepression drugs in last month; age above 18

Exclusion criteria: bipolar disorder type 1 & 2; cyclothymia; psychosis having other disorder of 1or 2 axis simultaneusly; drug addiction or withdrawal; medical disease which causes depression; pregnancy; breast feeding; cardiovascular disease history

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The effect of suicidal thoughts. Timepoint: 2, 24, 72 hours and 7 day after drug injection. Method of measurement: Beck suicidal ideation questionnaire.

Secondary Outcome Measures

Name	Time	Method
Quantity of depression. Timepoint: 2, 24, 72 hours and 7days after drug injectinon. Method of measurement: Beck depression questionaire.